| FOS - Proto-oncogene c-Fos |
|
| Date: 10/26/2012 2:02:35 PM | Name: Philip K. Liu |
| | Q3. Although antibodies have been proven to be specific for their TF proteins, we have developed a imaging-guided platform to deliver TF targeted MR contrast agents for intrecellular TFproteins as part of a research project RO1DA029889. This plateform applies double-straded DNA aptamer for delivery. This is a novel reagent and workable for in vivo bindingtesting and fits to reach inaccesseble tissue in clinical setting. |
|
